vs
FRIEDMAN INDUSTRIES INC（FRD）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是FRIEDMAN INDUSTRIES INC的1.2倍（$197.9M vs $168.0M），REPLIGEN CORP净利率更高（6.7% vs 1.8%，领先4.9%），FRIEDMAN INDUSTRIES INC同比增速更快（78.6% vs 13.6%），REPLIGEN CORP自由现金流更多（$17.6M vs $-6.3M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 13.3%）
赫尔曼与弗里德曼（H&F）是一家美国私募股权公司，由沃伦·赫尔曼与塔利·弗里德曼于1984年创立，主要通过杠杆收购及成长资本开展投资业务，核心投资方向覆盖传媒、金融服务、专业服务与信息服务等多个领域。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
FRD vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.2倍
$168.0M
营收增速更快
FRD
高出64.9%
13.6%
净利率更高
RGEN
高出4.9%
1.8%
自由现金流更多
RGEN
多$23.9M
$-6.3M
两年增速更快
RGEN
近两年复合增速
13.3%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $168.0M | $197.9M |
| 净利润 | $3.0M | $13.3M |
| 毛利率 | 2.3% | 52.5% |
| 营业利润率 | 2.3% | 9.0% |
| 净利率 | 1.8% | 6.7% |
| 营收同比 | 78.6% | 13.6% |
| 净利润同比 | 364.1% | 143.9% |
| 每股收益（稀释后） | $0.43 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FRDRGEN
| Q4 25 | $168.0M | $197.9M | ||
| Q3 25 | $152.4M | $188.8M | ||
| Q2 25 | $134.8M | $182.4M | ||
| Q1 25 | — | $169.2M | ||
| Q4 24 | $94.1M | $174.1M | ||
| Q3 24 | $106.8M | $154.9M | ||
| Q2 24 | $114.6M | $154.1M | ||
| Q1 24 | — | $151.3M |
净利润FRDRGEN
| Q4 25 | $3.0M | $13.3M | ||
| Q3 25 | $2.2M | $14.9M | ||
| Q2 25 | $5.0M | $14.9M | ||
| Q1 25 | — | $5.8M | ||
| Q4 24 | $-1.2M | $-30.3M | ||
| Q3 24 | $-675.0K | $-654.0K | ||
| Q2 24 | $2.6M | $3.3M | ||
| Q1 24 | — | $2.1M |
毛利率FRDRGEN
| Q4 25 | 2.3% | 52.5% | ||
| Q3 25 | 1.9% | 53.2% | ||
| Q2 25 | 5.2% | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | -0.2% | 50.0% | ||
| Q2 24 | -1.2% | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率FRDRGEN
| Q4 25 | 2.3% | 9.0% | ||
| Q3 25 | 1.9% | 8.9% | ||
| Q2 25 | 5.2% | 7.6% | ||
| Q1 25 | — | 3.9% | ||
| Q4 24 | -1.3% | -17.7% | ||
| Q3 24 | -0.2% | -5.1% | ||
| Q2 24 | -1.2% | 1.0% | ||
| Q1 24 | — | 1.3% |
净利率FRDRGEN
| Q4 25 | 1.8% | 6.7% | ||
| Q3 25 | 1.5% | 7.9% | ||
| Q2 25 | 3.7% | 8.2% | ||
| Q1 25 | — | 3.4% | ||
| Q4 24 | -1.2% | -17.4% | ||
| Q3 24 | -0.6% | -0.4% | ||
| Q2 24 | 2.2% | 2.2% | ||
| Q1 24 | — | 1.4% |
每股收益（稀释后）FRDRGEN
| Q4 25 | $0.43 | $0.24 | ||
| Q3 25 | $0.32 | $0.26 | ||
| Q2 25 | $0.71 | $0.26 | ||
| Q1 25 | — | $0.10 | ||
| Q4 24 | $-0.17 | $-0.55 | ||
| Q3 24 | $-0.10 | $-0.01 | ||
| Q2 24 | $0.37 | $0.06 | ||
| Q1 24 | — | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.0M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $142.2M | $2.1B |
| 总资产 | $311.9M | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资FRDRGEN
| Q4 25 | $3.0M | $767.6M | ||
| Q3 25 | $4.6M | $748.7M | ||
| Q2 25 | $2.1M | $708.9M | ||
| Q1 25 | — | $697.2M | ||
| Q4 24 | $1.1M | $757.4M | ||
| Q3 24 | $2.5M | $784.0M | ||
| Q2 24 | $4.1M | $809.1M | ||
| Q1 24 | — | $780.6M |
总债务FRDRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益FRDRGEN
| Q4 25 | $142.2M | $2.1B | ||
| Q3 25 | $139.3M | $2.1B | ||
| Q2 25 | $137.3M | $2.1B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | $127.3M | $2.0B | ||
| Q3 24 | $128.8M | $2.0B | ||
| Q2 24 | $129.7M | $2.0B | ||
| Q1 24 | — | $2.0B |
总资产FRDRGEN
| Q4 25 | $311.9M | $2.9B | ||
| Q3 25 | $311.3M | $2.9B | ||
| Q2 25 | $219.1M | $2.9B | ||
| Q1 25 | — | $2.9B | ||
| Q4 24 | $210.3M | $2.8B | ||
| Q3 24 | $209.2M | $2.8B | ||
| Q2 24 | $222.8M | $2.9B | ||
| Q1 24 | — | $2.8B |
负债/权益比FRDRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-4.7M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $-6.3M | $17.6M |
| 自由现金流率自由现金流/营收 | -3.8% | 8.9% |
| 资本支出强度资本支出/营收 | 1.0% | 4.1% |
| 现金转化率经营现金流/净利润 | -1.56× | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流FRDRGEN
| Q4 25 | $-4.7M | $25.7M | ||
| Q3 25 | $434.0K | $48.1M | ||
| Q2 25 | $15.5M | $28.6M | ||
| Q1 25 | — | $15.0M | ||
| Q4 24 | — | $39.2M | ||
| Q3 24 | — | $49.3M | ||
| Q2 24 | $-6.1M | $42.2M | ||
| Q1 24 | — | $44.7M |
自由现金流FRDRGEN
| Q4 25 | $-6.3M | $17.6M | ||
| Q3 25 | $-2.0M | $43.4M | ||
| Q2 25 | $13.7M | $21.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $33.6M | ||
| Q3 24 | — | $42.3M | ||
| Q2 24 | $-7.1M | $37.4M | ||
| Q1 24 | — | $36.4M |
自由现金流率FRDRGEN
| Q4 25 | -3.8% | 8.9% | ||
| Q3 25 | -1.3% | 23.0% | ||
| Q2 25 | 10.2% | 11.8% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | — | 19.3% | ||
| Q3 24 | — | 27.3% | ||
| Q2 24 | -6.2% | 24.3% | ||
| Q1 24 | — | 24.0% |
资本支出强度FRDRGEN
| Q4 25 | 1.0% | 4.1% | ||
| Q3 25 | 1.6% | 2.5% | ||
| Q2 25 | 1.3% | 3.9% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | 0.9% | 3.1% | ||
| Q1 24 | — | 5.5% |
现金转化率FRDRGEN
| Q4 25 | -1.56× | 1.93× | ||
| Q3 25 | 0.19× | 3.23× | ||
| Q2 25 | 3.08× | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -2.36× | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FRD
| Prime Coil | $152.0M | 90% |
| Manufactured Pipe | $14.9M | 9% |
| Customer Owned | $1.1M | 1% |
RGEN
暂无分部数据
